Phase II trial of PCNU in children with recurrent brain tumors and Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007263:Infusions, Parenteral; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009380:Neoplasms, Nerve Tissue / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use*
D009607:Nitrosourea Compounds; C018627:1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea